AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks 14 day Free Trial

CLEO DIAGNOSTICS LTD (COV)


AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for COV during the last 90 days, indicating Moderate trading activity

Latest COV Signals

12/05/2026BUY

COV Share Price

Current Price$0.500
52 Week High$0.865
52 Week Low:$0.335
Trading at (% of 52 Week High) 57.80%


Volume 95648
20 Day Avg 117067
Relative Volume 81.7%


Business Overview

Cleo Diagnostics Ltd (ASX: COV) is a healthcare technology company that develops and commercializes rapid diagnostic tests. The company focuses on providing point-of-care testing solutions for infectious diseases and other health conditions to improve patient outcomes.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for CLEO DIAGNOSTICS LTD (COV) is supported by positive momentum and potential growth in the diagnostics sector. However, the relatively low current price and limited market capitalization introduce moderate risk, warranting a cautious approach.

Latest  CLEO DIAGNOSTICS LTD(COV)   News

16 Jan 2026, 02:08 PM

ASX Penny Stocks Under A$500M Market Cap: 3 Promising Picks

The Australian market today presents a mixed outlook, with the Aussie dollar inching closer to 67 cents against the USD and equities poised for a flat opening. For investors interested in exploring beyond well-known names, penny stocks—typically smaller or newer companies—offer intriguing possib

24 Nov 2025, 07:01 AM

ASX Penny Stock Highlights Featuring Atturra And Two Others

The Australian market is experiencing a challenging period, with futures indicating a significant downturn and volatility on the rise. Despite these turbulent conditions, penny stocks—though an old-fashioned term—remain an intriguing area for investors seeking value in smaller or newer companies

24 Oct 2025, 07:02 AM

3 Promising ASX Penny Stocks With Market Caps Below A$3B

The Australian market showed a mixed performance recently, with energy stocks leading the way due to geopolitical factors and materials remaining steady. In this context, penny stocks continue to attract attention for their potential to offer unique growth opportunities. Although the term "penny sto

17 Sep 2025, 01:05 PM

ASX Penny Stocks To Watch In September 2025

As Australian shares edge towards a slight dip, global markets remain on edge awaiting the Federal Reserve's anticipated rate cut decision. Amidst these market fluctuations, the term "penny stocks" may seem outdated, yet they continue to offer intriguing opportunities for investors seeking affordabl

Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial